Literature DB >> 27090637

Zfp703 Is a Wnt/β-Catenin Feedback Suppressor Targeting the β-Catenin/Tcf1 Complex.

Amit Kumar1, Ravindra B Chalamalasetty1, Mark W Kennedy1, Sara Thomas1, Shreya N Inala1, Robert J Garriock1, Terry P Yamaguchi2.   

Abstract

The Wnt/β-catenin signaling pathway controls embryonic development and adult stem cell maintenance through the regulation of transcription. Failure to downregulate Wnt signaling can result in embryonic malformations and cancer, highlighting the important role of negative regulators of the pathway. The Wnt pathway activates several negative feedback targets, including axin2 and Dkk1, that function at different levels of the signaling cascade; however, none have been identified that directly target active β-catenin/Tcf1 transcriptional complexes. We show that Zfp703 is a Wnt target gene that inhibits Wnt/β-catenin activity in Wnt reporter assays and in Wnt-dependent mesoderm differentiation in embryonic stem cells. Zfp703 binds directly to Tcf1 to inhibit β-catenin/Tcf1 complex formation and does so independently of the Groucho/Tle transcriptional corepressor. We propose that Zfp703 is a novel feedback suppressor of Wnt/β-catenin signaling that functions by inhibiting the association of β-catenin with Tcf1 on Wnt response elements in target gene enhancers.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27090637      PMCID: PMC4907093          DOI: 10.1128/MCB.01010-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 2.  Hox genes and regional patterning of the vertebrate body plan.

Authors:  Moises Mallo; Deneen M Wellik; Jacqueline Deschamps
Journal:  Dev Biol       Date:  2010-05-07       Impact factor: 3.582

Review 3.  The links between axin and carcinogenesis.

Authors:  S Salahshor; J R Woodgett
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

Review 4.  Wnt/beta-catenin signaling in cancer stemness and malignant behavior.

Authors:  Riccardo Fodde; Thomas Brabletz
Journal:  Curr Opin Cell Biol       Date:  2007-02-16       Impact factor: 8.382

5.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

Authors:  O Aguilera; M F Fraga; E Ballestar; M F Paz; M Herranz; J Espada; J M García; A Muñoz; M Esteller; J M González-Sancho
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

6.  LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis.

Authors:  Juan Galceran; Claudio Sustmann; Shu-Chi Hsu; Stephanie Folberth; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

7.  Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development.

Authors:  V Brault; R Moore; S Kutsch; M Ishibashi; D H Rowitch; A P McMahon; L Sommer; O Boussadia; R Kemler
Journal:  Development       Date:  2001-04       Impact factor: 6.868

8.  Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs.

Authors:  R Coleman Lindsley; Jennifer G Gill; Theresa L Murphy; Ellen M Langer; Mi Cai; Mona Mashayekhi; Wei Wang; Noriko Niwa; Jeanne M Nerbonne; Michael Kyba; Kenneth M Murphy
Journal:  Cell Stem Cell       Date:  2008-07-03       Impact factor: 24.633

9.  CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer.

Authors:  Xuefeng Liu; Xiaomei Zhang; Qimin Zhan; Malcolm V Brock; James G Herman; Mingzhou Guo
Journal:  Cancer Biol Ther       Date:  2012-08-23       Impact factor: 4.742

10.  ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.

Authors:  Fabrice Sircoulomb; Nathalie Nicolas; Anthony Ferrari; Pascal Finetti; Ismahane Bekhouche; Estelle Rousselet; Aurélie Lonigro; José Adélaïde; Emilie Baudelet; Séverine Esteyriès; Julien Wicinski; Stéphane Audebert; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Marc Lopez; Jean-Paul Borg; Christos Sotiriou; Cornel Popovici; François Bertucci; Daniel Birnbaum; Max Chaffanet; Christophe Ginestier
Journal:  EMBO Mol Med       Date:  2011-02-15       Impact factor: 12.137

View more
  7 in total

Review 1.  Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma.

Authors:  L K Kadian; M Arora; C P Prasad; R Pramanik; S S Chauhan
Journal:  Clin Transl Oncol       Date:  2022-01-06       Impact factor: 3.405

2.  Limb Mesoderm and Head Ectomesenchyme Both Express a Core Transcriptional Program During Chondrocyte Differentiation.

Authors:  Patsy Gomez-Picos; Katie Ovens; B Frank Eames
Journal:  Front Cell Dev Biol       Date:  2022-06-17

Review 3.  Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.

Authors:  Roya Tabatabai; Yuliya Linhares; David Bolos; Monica Mita; Alain Mita
Journal:  Target Oncol       Date:  2017-10       Impact factor: 4.864

4.  Early molecular events during retinoic acid induced differentiation of neuromesodermal progenitors.

Authors:  Thomas J Cunningham; Alexandre Colas; Gregg Duester
Journal:  Biol Open       Date:  2016-12-15       Impact factor: 2.422

5.  Znf703 is a novel RA target in the neural plate border.

Authors:  Amanda Janesick; Weiyi Tang; Kristen Ampig; Bruce Blumberg
Journal:  Sci Rep       Date:  2019-06-04       Impact factor: 4.379

6.  TMEM88 Inhibits Wnt Signaling by Promoting Wnt Signalosome Localization to Multivesicular Bodies.

Authors:  Heejin Lee; Todd Evans
Journal:  iScience       Date:  2019-07-29

Review 7.  WNT Signaling in Melanoma.

Authors:  Anna Gajos-Michniewicz; Malgorzata Czyz
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.